Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Respicardia Announces Enrollment Of First Patients In Pivotal Trial Of The remede® System For The Treatment Of Central Sleep Apnea

03:13 EDT 19 Aug 2013 | PR Newswire
This article has expired, however you can still download the PDF.
Preview:
MINNEAPOLIS, Aug. 19, 2013 /PRNewswire/ -- Respicardia®, a developer of implantable therapies to improve respiratory and cardiovascular health, announced that the first patients have been enrolled in the pivotal trial to evaluate the reme...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Respicardia Announces Enrollment Of First Patients In Pivotal Trial Of The remede® System For The Treatment Of Central Sleep Apnea"

Search BioPortfolio:
Advertisement
Advertisement

Searches Linking to this Story